A. Necchi Et Al. , "Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party," BONE MARROW TRANSPLANTATION , vol.51, no.3, pp.384-390, 2016
Necchi, A. Et Al. 2016. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party. BONE MARROW TRANSPLANTATION , vol.51, no.3 , 384-390.
Necchi, A., Miceli, R., Bregni, M., BOKEMEYER, C., Berger, L. A., Oechsle, K., ... Schumacher, K.(2016). Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party. BONE MARROW TRANSPLANTATION , vol.51, no.3, 384-390.
Necchi, A. Et Al. "Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party," BONE MARROW TRANSPLANTATION , vol.51, no.3, 384-390, 2016
Necchi, A. Et Al. "Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party." BONE MARROW TRANSPLANTATION , vol.51, no.3, pp.384-390, 2016
Necchi, A. Et Al. (2016) . "Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party." BONE MARROW TRANSPLANTATION , vol.51, no.3, pp.384-390.
@article{article, author={A. Necchi Et Al. }, title={Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party}, journal={BONE MARROW TRANSPLANTATION}, year=2016, pages={384-390} }